Cargando…
Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases
The problems with anticancer therapy are resistance and toxicity. From 3000 Cisplatin derivatives tested as antitumor agents, most of them have been rejected, due to toxicity. The aim of current study is the comparison of therapeutic combinations of the currently applied in clinical practice: Cispla...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031877/ https://www.ncbi.nlm.nih.gov/pubmed/35458666 http://dx.doi.org/10.3390/molecules27082466 |